A
Alcista
Alcista · 25%DSS
$0.63
Precio del escenario
$0.510
-0.007 (-1.39%)Al cierre
Loading chart…
- Máximo
- 0.548
- Apertura
- 0.510
- Precio medio ponderado por volumen
- 0.52
- Volumen
- 8.78K
- Capitalización
- 12.39M
- Mínimo
- 0.510
- Importe
- 4.59K
- EV/EBITDA, TTM
- 0.00
DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.
Análisis de IA of DSS Inc (DSS)
VenderDSS Inc is not a good buy right now due to its extremely low RSI of 11.84, indicating it is oversold, and a significant year-to-date change of -47.49%. The company is facing severe financial difficulties, with a gross margin of -25.39% in Q2 2026 and a net income loss of $4,789,000 in the same quarter. The main risk is the ongoing insider selling, with plans to sell $23.06 million in common stock, which could further depress the stock price.
Métricas de valoración
El PER previsto actual de DSS Inc (DSS) es 0.00, frente a su media de 5 años de -1.42.
Escenarios de precio de Alphio AI para DSS
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
8.509-04NewsfilterDSS Inc. Cancels Proposed Public Offering
- 8.509-04Newsfilter
DSS, Inc. Launches Public Offering of Common Stock
- 8.506-09Newsfilter
DSS Withdraws S-1 Registration Statement Amid Market Conditions
- 9.505-08Newsfilter
DSS Announces 2025 Fiscal Year Audit Report with Going Concern Qualification
5.004-29moomooInsider at DSS Inc (DSS.US) Plans to Sell $23.06 Million in Common Stock via Form 144
Preguntas frecuentes sobre DSS, respondidas por Alphio AI
DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing. It operates in the Basic Materials sector (PAPERBOARD CONTAINERS & BOXES industry).
DSS Inc is not a good buy right now due to its extremely low RSI of 11.84, indicating it is oversold, and a significant year-to-date change of -47.49%. The company is facing severe financial difficulties, with a gross margin of -25.39% in Q2 2026 and a net income loss of $4,789,000 in the same quarter. The main risk is the ongoing insider selling, with plans to sell $23.06 million in common stock, which could further depress the stock price.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.